Ted Okon, MBA, executive director of the Community Oncology Alliance, spoke with The American Journal of Managed Care® about how the Federal Trade Commission's (FTC) lawsuit against pharmacy benefit ...

The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...

FTC files lawsuit against top PBMs and GPOs for alleged anticompetitive practices in inflating insulin prices. Learn about the allegations and responses.

In a landmark move, the FTC filed a lawsuit targeting the “Big Three” PBMs: CVS Health’s Caremark Rx, Cigna’s Express Scripts (ESI), and UnitedHealth Group’s OptumRx. The suit also includes their ...

In a move to address escalating insulin prices, the Federal Trade Commission (FTC) has initiated action against the three ...

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...

Unsurprisingly, CVS Health, Cigna, and UnitedHealth Group stocks fell last week after the FTC lawsuit announcement. But are ...

The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebatin ...

This week's healthcare newsletter looks at the prospect for prior authorization reform for prescription drugs and a major FTC ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...